TY - JOUR
T1 - Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke
T2 - The Liverpool-Huawei stroke study
AU - Harrison, Stephanie L.
AU - Buckley, Benjamin J.R.
AU - Zheng, Yalin
AU - Hill, Andrew
AU - Hlaing, Thant
AU - Davies, Ruth
AU - Guo, Yutao
AU - Lane, Deirdre A.
AU - Lip, Gregory Y.H.
AU - Liverpool-Huawei Stroke Study Investigators
AU - Choi, Sylvia
AU - Elsheikh, Sandra
AU - Sagris, Dimitrios
AU - Joddrell, Martha
AU - Alobaida, Muath
AU - McCarthy, Elizabeth
AU - Eustace, Ian
AU - Hoad, S. J.Katie
AU - Logantha, Sunil Jit R.J.
AU - McDowell, Garry
AU - Shantsila, Alena
AU - Gue, Ying
AU - Isanejad, Masoud
AU - Isanejad, Masoud
AU - Jones, Ian
PY - 2023/3
Y1 - 2023/3
N2 - Background: Atrial fibrillation (AF) often remains undetected following stroke. Documenting AF is critical to initiate oral anticoagulation, which has proven benefit in reducing recurrent stroke and mortality in patients with AF. The accuracy and acceptability of using smart wearables to detect AF in patients following stroke is unknown. Methods: The aims of the Liverpool-Huawei Stroke Study are to determine the effectiveness, cost-effectiveness and patient and staff acceptability of using Huawei smart wearables to detect AF following ischemic stroke. The study plans to recruit 1,000 adults aged ≥18 years following ischemic stroke from participating hospitals over 12 months. All participants will be asked to wear a Huawei smart band for 4 weeks postdischarge. If participants do not have access to a compatible smartphone required for the study, they will be provided with a smartphone for the 4-week AF monitoring period. Results: Participants with suspected AF detected by the smart wearables, without previous known AF, will be referred for further evaluation. To determine the effectiveness of the Huawei smart wearables to detect AF, the positive predictive value will be determined. Patient acceptability of using this technology will also be examined. Additional follow-up assessments will be conducted at 6 and 12 months, and clinical outcomes recorded in relation to prevalent and incident AF post-stroke. The study opened for recruitment on May 30, 2022, and is currently open at 4 participating hospitals; the first 106 participants have been recruited. One further hospital is preparing to open for recruitment. Conclusions: This prospective study will examine the effectiveness and acceptability of the use of smart wearables in patients following ischemic stroke. This could have important implications for detection of AF and therefore, earlier prophylaxis for recurrent stroke. The study is registered on https://www.isrctn.com/ (Identifier ISRCTN30693819).
AB - Background: Atrial fibrillation (AF) often remains undetected following stroke. Documenting AF is critical to initiate oral anticoagulation, which has proven benefit in reducing recurrent stroke and mortality in patients with AF. The accuracy and acceptability of using smart wearables to detect AF in patients following stroke is unknown. Methods: The aims of the Liverpool-Huawei Stroke Study are to determine the effectiveness, cost-effectiveness and patient and staff acceptability of using Huawei smart wearables to detect AF following ischemic stroke. The study plans to recruit 1,000 adults aged ≥18 years following ischemic stroke from participating hospitals over 12 months. All participants will be asked to wear a Huawei smart band for 4 weeks postdischarge. If participants do not have access to a compatible smartphone required for the study, they will be provided with a smartphone for the 4-week AF monitoring period. Results: Participants with suspected AF detected by the smart wearables, without previous known AF, will be referred for further evaluation. To determine the effectiveness of the Huawei smart wearables to detect AF, the positive predictive value will be determined. Patient acceptability of using this technology will also be examined. Additional follow-up assessments will be conducted at 6 and 12 months, and clinical outcomes recorded in relation to prevalent and incident AF post-stroke. The study opened for recruitment on May 30, 2022, and is currently open at 4 participating hospitals; the first 106 participants have been recruited. One further hospital is preparing to open for recruitment. Conclusions: This prospective study will examine the effectiveness and acceptability of the use of smart wearables in patients following ischemic stroke. This could have important implications for detection of AF and therefore, earlier prophylaxis for recurrent stroke. The study is registered on https://www.isrctn.com/ (Identifier ISRCTN30693819).
KW - Wearable devices
KW - Huawei
KW - Atrial fibrillation
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85145999060&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2022.12.004
DO - 10.1016/j.ahj.2022.12.004
M3 - Article
C2 - 36493841
AN - SCOPUS:85145999060
SN - 0002-8703
VL - 257
SP - 103
EP - 110
JO - American Heart Journal
JF - American Heart Journal
ER -
